Monotherapy activity with inhaled KB707 provides further evidence of successful repeat administration of HSV-1 based inhaled lung gene delivery and builds on recent clinical data update for CF and AAT ...

Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...

A spotlight is shining on 1 article each day through New Year’s Eve, when the No. 1 dvm360 story of the year will be shared. The following article is No. 16 on this list: ...

Hand, foot and mouth disease (HFMD) is a very common viral infection that predominantly affects children under the age of 5, ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

FLASH2 Study opens patient enrollment PRINCETON, N.J., Dec. 16, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused ...

The following is a summary of “How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site ...

A national survey highlighted scars, acne, and hyperhidrosis as the most commonly treated pediatric cosmetic conditions, with ...

Wound healing is a core skill in dermatology, but true expertise involves incorporating new techniques with the medical school basics to address challenging cases.

A new study highlights that melanoma patients with tumors between 0.8 to 1.0 mm thick face significantly higher mortality ...